Background Patients with incomplete surgical resection of medulloblastoma are
controversially regarded as having a marker of high-risk disease, which leads to patients …

Background Although the majority of current medulloblastoma adjuvant therapy protocols
treat patients with≥ 1.5 cm 2 residual tumor as high risk with increased craniospinal …

Although the posterior fossa syndrome (PFS) can be considered as an aetiologically
heterogeneous condition affecting children and adults, it most often occurs in paediatric …

Effective treatment of children with medulloblastoma requires a functioning multi‐disciplinary
team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and …

Background Posterior fossa syndrome (PFS) is defined as the temporary and complete loss
of speech after posterior fossa surgery. The goal of this study was to identify incidence and …

PURPOSE Medulloblastoma is composed of four clinically and prognostically distinct
molecular subgroups (WNT, SHH, group 3, and group 4). However, the clinical implications …

The altered metabolism of cancer cells has long been viewed as a potential target for
therapeutic intervention. In particular, brain tumors often display heightened glycolysis, even …

Methods A retrospective analysis was conducted, involving 284 patients treated at 21
pediatric oncology centers in Mexico. Results High-risk patients exhibited markedly lower …

Introduction Information about pediatric survivors of brain tumors in developing countries is
scant. Purpose In this study, we aimed to investigate the availability of resources for …

Medulloblastoma, the most common malignant brain tumor in children, presents a complex
treatment challenge due to its propensity for infiltrative growth within the posterior fossa and …